- Home
- SMX vs PMCB Comparison
SMX vs PMCB Comparison
Compare SMX & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMX
- PMCB
- Stock Information
- Founded
- SMX N/A
- PMCB 1996
- Country
- SMX Ireland
- PMCB United States
- Employees
- SMX N/A
- PMCB N/A
- Industry
- SMX Industrial Machinery/Components
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SMX Technology
- PMCB Health Care
- Exchange
- SMX Nasdaq
- PMCB Nasdaq
- Market Cap
- SMX 6.7M
- PMCB 6.6M
- IPO Year
- SMX N/A
- PMCB N/A
- Fundamental
- Price
- SMX $1.39
- PMCB $0.93
- Analyst Decision
- SMX
- PMCB
- Analyst Count
- SMX 0
- PMCB 0
- Target Price
- SMX N/A
- PMCB N/A
- AVG Volume (30 Days)
- SMX 9.0M
- PMCB 106.5K
- Earning Date
- SMX 01-01-0001
- PMCB 09-15-2025
- Dividend Yield
- SMX N/A
- PMCB N/A
- EPS Growth
- SMX N/A
- PMCB N/A
- EPS
- SMX N/A
- PMCB 0.01
- Revenue
- SMX N/A
- PMCB N/A
- Revenue This Year
- SMX N/A
- PMCB N/A
- Revenue Next Year
- SMX N/A
- PMCB N/A
- P/E Ratio
- SMX N/A
- PMCB $160.47
- Revenue Growth
- SMX N/A
- PMCB N/A
- 52 Week Low
- SMX $1.10
- PMCB $0.80
- 52 Week High
- SMX $4,437.94
- PMCB $2.42
- Technical
- Relative Strength Index (RSI)
- SMX 28.10
- PMCB 44.27
- Support Level
- SMX $1.30
- PMCB $1.00
- Resistance Level
- SMX $1.56
- PMCB $1.08
- Average True Range (ATR)
- SMX 0.36
- PMCB 0.08
- MACD
- SMX 0.44
- PMCB -0.00
- Stochastic Oscillator
- SMX 17.65
- PMCB 2.95
About SMX SMX (Security Matters) Public Limited Company
SMX (Security Matters) PLC provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader, and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.